Science & Enterprise subscription

Follow us on Twitter

  • A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations an…
    about 17 hours ago
  • Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with dec…
    about 21 hours ago
  • New post on Science and Enterprise: Q3 Venture Investing Falls, Biotech Remains Hot #Science #Business
    about 22 hours ago
  • While a majority of Americans say they trust research findings that are open to public inspection, about the same n…
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public Down on Industry-Funded Science #Science #Business
    about 3 days ago

Please share Science & Enterprise

Infographic – Microsoft, IBM Lead A.I. Patent Race

A.I. patent chart

Click on image for full-size view. (Statista)

1 June 2019. Artificial intelligence, or A.I., in its various forms are a continuing focus of researchers across many disciplines, and the world’s leading technology companies are in a race to turn these discoveries into products and services. The market intelligence company iPlytics GmbH in Berlin published a report in April on A.I.-related patents owned by technology companies, which our friends at Statista on Wednesday compiled into a chart, this weekend’s infographic.

The data show as of January 2019, Microsoft leads in the number of A.I. patents in its portfolio with more than 18,300, followed by IBM with about 15,000 patents. Device and chip makers Samsung, Qualcomm, and Google are next, each with about 9,500 to 11,200 patents. Philips, Siemens, Sony, Intel, and Canon round out the top 10.

The iPlytics report also tallied the number of patent applications for A.I.-related technologies over the past several years, which shows the rapid growth of this field. In 2008, nearly 23,000 A.I.-related patent applications were filed, and by last year that number jumped to some 78,000.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...

Comments are closed.